Académique Documents
Professionnel Documents
Culture Documents
Apr
2015
May
2015
June
2015
July
2015
Aug
2015
Sep
2015
Oct
2015
Parameter
Presentati
on done
in the
meeting
on
15 May
15
CAPA prepared
and Submitted
on
15 Jun 15
15 Jun 15
15 May 15
15 Jul 15
15 Jul 15
15 Aug 15
15 Aug 15
15 Sep 15
15Sep 15
17 Oct 15
17 Oct 15
27 Nov 15
27 Nov 15
CABG patient.
2. Assessment of the benchmark glycoprotein
IIb/IIIa inhibitors should not be used in more
than 15% of angioplasty patients.
Nov
2015
Dec
2015
Jan
2016
Feb
2016
Mar
2016
Apr
2016